Familial pulmonary hypoplasia: plain film appearances with histopathological correlation

R A Green1, D G Shaw, S G Haworth

  • 1Department of Radiology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1 3JH, UK.

Pediatric Radiology
|June 17, 1999
PubMed

Insights

Familial pulmonary hypoplasia, a rare condition causing underdeveloped lungs, was studied in an infant. Advanced imaging clarified the primitive lung architecture in this unique case.

Area of Science:

  • Pediatric Radiology
  • Pulmonology
  • Medical Genetics

Background:

  • Familial pulmonary hypoplasia is a rare genetic disorder leading to bilateral pulmonary hypoplasia.
  • Understanding the radiological and histopathological features is crucial for diagnosis and management.

Observation:

  • A case of familial pulmonary hypoplasia in an infant who survived for 5 weeks is presented.
  • Plain film radiography was used to visualize the lung structures.
  • Histopathological examination provided detailed insights into the lung architecture.

Findings:

  • The study correlated plain film radiographic findings with histopathological results.
  • Improved medical technology allowed for prolonged survival, enabling clearer visualization of the primitive lung architecture.
  • Radiological features of the underdeveloped lung were distinctly observed.

Implications:

  • This case highlights the utility of advanced imaging in defining the characteristics of rare congenital lung anomalies.
  • The findings contribute to the understanding of familial pulmonary hypoplasia and its presentation.
  • Further research into genetic and imaging correlations may improve early detection and intervention strategies for pulmonary hypoplasia.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...